Moderna, Inc. earnings per share and revenue

MRNA earnings per share for the last quarter are 0.55 USD whereas the estimation was -0.99 USD which accounts for 155.74% surprise. Company revenue for the same period amounts to 2.81 B USD despite the estimated figure of 2.51 B USD. Estimated earnings per share for the next quarter are -3.56 USD, and revenue is expected to reach 93.26 M USD. Also watch annual changes over time to get a bigger picture of MRNA earnings per share and revenue dynamics.